Allstate Corporation’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,956
| Closed | -$290K | – | 451 |
|
|
2022
Q4 | $290K | Buy |
3,956
+85
| +2% | +$6.24K | 0.01% | 554 |
|
|
2022
Q3 | $294K | Sell |
3,871
-18
| -0.5% | -$1.37K | 0.01% | 560 |
|
|
2022
Q2 | $270K | Sell |
3,889
-791
| -17% | -$54.9K | 0.01% | 578 |
|
|
2022
Q1 | $388K | Buy |
+4,680
| New | +$388K | 0.01% | 540 |
|
|
2021
Q4 | – | Sell |
-2,979
| Closed | -$346K | – | 756 |
|
|
2021
Q3 | $346K | Buy |
2,979
+519
| +21% | +$60.3K | 0.01% | 593 |
|
|
2021
Q2 | $546K | Buy |
+2,460
| New | +$546K | 0.02% | 500 |
|
|
2021
Q1 | – | Sell |
-1,195
| Closed | -$207K | – | 737 |
|
|
2020
Q4 | $207K | Buy |
+1,195
| New | +$207K | 0.01% | 692 |
|